Analystreport

Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $4.00 to $7.00.

Harvard Bioscience, Inc.  (HBIO) 
Last harvard bioscience, inc. earnings: 2/26 07:15 am Check Earnings Report
US:NASDAQ Investor Relations: investor.harvardbioscience.com